Drug Profile
Meningococcal vaccine groups A and C conjugate - Chiron
Latest Information Update: 15 Aug 2007
Price :
$50
*
At a glance
- Originator Chiron Corporation
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Meningococcal group A infections; Meningococcal group C infections